Neumora Therapeutics, Inc. Common Stock
NMRA Real Time Price USDRecent trades of NMRA by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NMRA's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
NMRA Revenue by Segment or Geography
New patents grants
-
Patent Title: System and method of facial analysis Feb. 25, 2025
-
Patent Title: Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto Dec. 24, 2024
-
Patent Title: Vasopressin receptor antagonists and products and methods related thereto Nov. 26, 2024
-
Patent Title: Multimodal dynamic attention fusion Sep. 10, 2024
-
Patent Title: Machine learning-based diagnostic classifier Jun. 04, 2024
-
Patent Title: Methods of treating neurological disorders May. 28, 2024
-
Patent Title: System and method for identifying transdiagnostic features shared across mental health disorders Mar. 26, 2024
-
Patent Title: Estimating uncertainty in predictions generated by machine learning models Jan. 30, 2024
-
Patent Title: Vasopressin receptor antagonists and products and methods related thereto Jan. 02, 2024
-
Patent Title: Systems and methods for screening, diagnosing, and stratifying patients Jan. 02, 2024
-
Patent Title: Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject Dec. 12, 2023
-
Patent Title: Machine learning systems for training encoder and decoder neural networks Oct. 24, 2023
-
Patent Title: Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping data Oct. 17, 2023
-
Patent Title: Machine learning systems for generating multi-modal data archetypes Aug. 29, 2023
-
Patent Title: Machine learning-based diagnostic classifier Aug. 01, 2023
-
Patent Title: Machine learning-based diagnostic classifier Jun. 13, 2023
-
Patent Title: Machine learning systems for processing multi-modal patient data Jun. 06, 2023
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to NMRA
Number of mentions of NMRA in WallStreetBets Daily Discussion
Recent picks made for NMRA stock on CNBC
ETFs with the largest estimated holdings in NMRA
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NMRA stock a Buy, Sell, or Hold?
- What is the price target for $NMRA stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NMRA stock?
- Who owns the most shares of $NMRA stock?
- What funds own $NMRA stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NMRA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.